COVID-19 Critical Response Program
If you represent a group that is developing a digital or mobile product specifically to diagnose, contain, treat or prevent COVID-19, Syncro offers rapid deployment at a subsidized cost through its COVID-19 Critical Response Program.
Our team is ready to help – COVID-19 Critical Response Program
Syncro is committed to honoring our healthcare providers and in helping our world confront the COVID-19 pandemic. We have allocated engineering and development teams to work directly with companies, organizations or healthcare systems at a rapid pace and a reduced cost. We can deploy researchers, engineers, developers, data scientists, and quality analysts operating within our ISO-13485 certified environment to help launch data services, digital devices or mobile apps aimed specifically to diagnose, contain, treat or prevent COVID-19.
We have resources available to accelerate life science, medical device, and pharmaceutical projects in the following areas:
- Diagnostic Instruments
- Mobile Apps
- Remote Patient Monitoring
- Data Analysis & Simulation
- AI & Machine Learning
- Medical IoT
- Patient Guidance
- Digital Therapeutics
- Cloud Services & Connectivity
If you are undertaking a rapid ramp-up for a critical COVID-19 life-saving project, we can help. We have allocated engineering and development teams to work directly at a rapid pace and a reduced cost.
Please reach out to our team.
FDA COVID-19 GUIDANCE SUMMARIES
The FDA is releasing new guidance documents to help product developers navigate the rapidly evolving regulatory landscape.
At Syncro Medical, we understand that our partners and industry peers are being inundated with information while pivoting their strategies to meet current and future needs. To help you quickly move forward, we extracted need-to-know information from the latest COVID-19 medical device guidance.
CONTACT SYNCRO MEDICAL’S
COVID-19 CRITICAL RESPONSE TEAM